<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although, astrocytes are more resistant than neurons to ischemic injury, astrocyte <z:hpo ids='HP_0011420'>death</z:hpo> has been demonstrated in animal models of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Astrocytes <z:hpo ids='HP_0011420'>death</z:hpo> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion may strongly affect neuronal survival because of the absence of their trophic and metabolic support to neurons, and astrocytic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> uptake </plain></SENT>
<SENT sid="2" pm="."><plain>Early signals involved in astrocytes <z:hpo ids='HP_0011420'>death</z:hpo> are poorly understood </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrated enhanced and mostly cytoplasmic activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) during <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of cultured astrocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with UO126, inhibitor of MEK1, threo-beta-benzyloxyaspartic acid, <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter inhibitor, and FK506, a cytoprotective drug prevented ERK activation and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Over-expression of ERK dual specificity phosphatases 5 and 6 <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> in transfected astrocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Prolonged ERK1/2 activation was observed in ischemic brain: in the nucleus and cytoplasm of astrocytes in the cerebral cortex, and exclusively in the cytoplasm of astrocytes in the striatum </plain></SENT>
<SENT sid="7" pm="."><plain>Global gene expression profiling in the cortex revealed that FK506 blocks middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>-induced expression of numerous genes associated with ERK signaling pathway and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>The results demonstrate a pro-apoptotic role of sustained activation of ERK1/2 signaling in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced <z:hpo ids='HP_0011420'>death</z:hpo> of astrocytes and the ability of FK506 to block both ERK activation and astrocytic cell <z:hpo ids='HP_0011420'>death</z:hpo> in vitro and in ischemic brains </plain></SENT>
</text></document>